EXPO Exponent Inc

Price (delayed)

$91.98

Market cap

$4.68B

P/E Ratio

46.45

Dividend/share

$0.98

EPS

$1.98

Enterprise value

$4.57B

Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's interdisciplinary organization of scientists, physicians, engineers, and business consultants draws from more than 90 technical disciplines ...

Highlights
The company's debt fell by 12% QoQ and by 3% YoY
The revenue has grown by 10% YoY and by 2.3% from the previous quarter
EXPO's quick ratio is up by 32% since the previous quarter but it is down by 17% year-on-year
EXPO's gross profit is up by 15% YoY but it is down by 3.6% from the previous quarter

Key stats

What are the main financial stats of EXPO
Market
Shares outstanding
50.84M
Market cap
$4.68B
Enterprise value
$4.57B
Valuations
Price to earnings (P/E)
46.45
Price to book (P/B)
13.63
Price to sales (P/S)
8.96
EV/EBIT
33.84
EV/EBITDA
32.08
EV/Sales
8.7
Earnings
Revenue
$525.12M
EBIT
$134.97M
EBITDA
$142.34M
Free cash flow
$78.35M
Per share
EPS
$1.98
Free cash flow per share
$1.53
Book value per share
$6.75
Revenue per share
$10.27
TBVPS
$10.91
Balance sheet
Total assets
$566.43M
Total liabilities
$224.57M
Debt
$16.45M
Equity
$341.86M
Working capital
$209.12M
Liquidity
Debt to equity
0.05
Current ratio
2.92
Quick ratio
2.74
Net debt/EBITDA
-0.77
Margins
EBITDA margin
27.1%
Gross margin
30.2%
Net margin
19.4%
Operating margin
25.4%
Efficiency
Return on assets
17.9%
Return on equity
30.9%
Return on invested capital
45.8%
Return on capital employed
29.5%
Return on sales
25.7%
Dividend
Dividend yield
1.07%
DPS
$0.98
Payout ratio
49.5%

EXPO stock price

How has the Exponent stock price performed over time
Intraday
2.71%
1 week
3.67%
1 month
-2.37%
1 year
2.54%
YTD
-7.18%
QTD
-7.73%

Financial performance

How have Exponent's revenue and profit performed over time
Revenue
$525.12M
Gross profit
$158.52M
Operating income
$133.25M
Net income
$101.85M
Gross margin
30.2%
Net margin
19.4%
EXPO's gross profit is up by 15% YoY but it is down by 3.6% from the previous quarter
The company's operating income rose by 10% YoY but it fell by 5% QoQ
The revenue has grown by 10% YoY and by 2.3% from the previous quarter
The company's net margin fell by 7% YoY and by 2.5% QoQ

Growth

What is Exponent's growth rate over time

Valuation

What is Exponent stock price valuation
P/E
46.45
P/B
13.63
P/S
8.96
EV/EBIT
33.84
EV/EBITDA
32.08
EV/Sales
8.7
The price to earnings (P/E) is 6% lower than the 5-year quarterly average of 49.6 and 4.4% lower than the last 4 quarters average of 48.6
EXPO's EPS is up by 4.8% year-on-year
The P/B is 15% above the 5-year quarterly average of 11.9 but 7% below the last 4 quarters average of 14.6
The equity has contracted by 12% YoY but it has grown by 7% from the previous quarter
The revenue has grown by 10% YoY and by 2.3% from the previous quarter
The price to sales (P/S) is 9% lower than the 5-year quarterly average of 9.8 and 7% lower than the last 4 quarters average of 9.6

Efficiency

How efficient is Exponent business performance
Exponent's return on equity has increased by 24% YoY and by 3% QoQ
EXPO's ROA is up by 15% YoY
EXPO's return on sales is down by 4.5% year-on-year
The company's return on invested capital fell by 2.3% YoY

Dividends

What is EXPO's dividend history
DPS
$0.98
Dividend yield
1.07%
Payout ratio
49.5%
Recent dividends

Financial health

How did Exponent financials performed over time
EXPO's total assets is 152% greater than its total liabilities
The current ratio rose by 33% since the previous quarter but it has declined by 15% year-on-year
EXPO's quick ratio is up by 32% since the previous quarter but it is down by 17% year-on-year
The company's debt is 95% lower than its equity
The debt to equity has increased by 25% year-on-year but it has declined by 17% since the previous quarter
The equity has contracted by 12% YoY but it has grown by 7% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.